Ocena jakości snu w odniesieniu do stężenia serotoniny i melatoniny w surowicy u osób z marskością wątroby

• Authors: Karolina Tomaszewska-Warda , Ewa Walecka-Kapica , Monika Pawłowicz , Patrycja Wachowska-Kelly , Cezary Chojnacki

Title variants

EN

Evaluation of the quality of sleep in relation to serotonin and melatonin levels in patients with liver cirrhosis

• Languages of publication: PL

Abstracts

EN

Sleep disorders occur in people who suffer from liver cirrhosis, this usually involves a change in the rhythm of melatonin secretion and its metabolism. Delayed sleep phase syndrome does not always correlate with the degree of liver damage, indicating the involvement of other factors in its pathogenesis. The aim of the study was to estimate the correlation between the night secretion of the serotonin and melatonin and the degree of sleep disorders. There were 60 patients with liver cirrhosis and 30 healthy subjects (control group) included in the study. Compared to the control group, in the first stage of hepatic encephalopathy (according to West Haven Scale) at 2 o’clock a.m. a low serum melatonin level was observed (57.5±10.2 pg/mL and 41.2±9.4 pg/mL, p<0.05) and even lower concentration of serotonin (171.2±45.0 and 108.4±29.3 μg/mL, p<0.01). These results negatively correlated with the degree of sleep disorders. The obtained results indicate that in patients with liver cirrhosis the changes in the homeostasis of both serotonin and melatonin occur, which can cause sleep disorders.

PL

U osób z marskością wątroby występują zaburzenia snu, co zwykle wiąże się ze zmianą rytmu wydzielania melatoniny i jej metabolizmu. Zespół opóźnionej fazy snu nie zawsze koreluje ze stopniem uszkodzenia wątroby, co wskazuje na udział innych czynników w jego patogenezie. Celem badania było określenie zależności między nocnym wydzielaniem serotoniny i melatoniny a stopniem zaburzeń snu. Do badań włączono 60 osób z marskością wątroby (grupa badana) i 30 osób zdrowych (grupa kontrolna). W porównaniu do grupy kontrolnej, u chorych z pierwszym stopniem encefalopatii wątrobowej (wg skali West Haven) o godzinie 2:00 stwierdzono niższe stężenie melatoniny w surowicy (odpowiednio 57,5±10,2 pg/mL i 41,2±9,4 pg/mL, p<0,05), zaś u osób z drugim stopniem encefalopatii - niższe stężenie serotoniny (odpowiednio 171,2±45,0 i 108,4±29,3

Keywords

EN

cirrhosis; encefalopatia; encephalopathy; marskość wątroby; melatonin; melatonina; serotonin; serotonina; sleep disorder; zaburzenia snu

Discipline

• MEDICINE: MEDICINE

• Journal: Folia Medica Lodziensia
• Year: 2014
• Volume: 41
• Issue: 2
• Pages: 169-180

Contributors

author

Karolina Tomaszewska-Warda

• Klinika Gastroenterologii, Uniwersytet Medyczny w Łodzi,

author

Ewa Walecka-Kapica

• Zakład Żywienia Klinicznego i Diagnostyki Gastroenterologicznej, Uniwersytet Medyczny w Łodzi

author

Monika Pawłowicz

• Klinika Gastroenterologii, Uniwersytet Medyczny w Łodzi

author

Patrycja Wachowska-Kelly

• Klinika Gastroenterologii, Uniwersytet Medyczny w Łodzi

author

Cezary Chojnacki

• Zakład Żywienia Klinicznego i Diagnostyki Gastroenterologicznej, Uniwersytet Medyczny w Łodzi

References

• Butterworth RF. Hepatic encephalopathy. Alcohol Res Health. 2003; 27(3): 240-246.
• Bergeron M, Swain MS, Reader TA, Grondin L, Butterworth RF. Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat. J Neurochem. 1990; 55(1): 222-229.
• Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B. Neurological and neuropsychiatric syndromes associated with liver disease. AIDS. 2005; 19 (Suppl 3): S93-98.
• Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003; 66(9): 1673-1680.
• Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013; 20(1): 14-21.
• Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci. 2008; 12(1): 31-40.
• Karasek M, Winczyk K. Melatonin in humans. J Physiol Pharmacol. 2006; 57 Suppl 5: 19-39.
• Rodenbeck A, Huether G, Ruther E, Hajak G. Nocturnal melatonin secretion and its modification by treatment in patients with sleep disorders. Adv Exp Med Biol. 1999; 467: 89-93.
• Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R i wsp. Melatonin and melatonergic drugs on sleep: possible mechanisms of action. Int J Neurosci. 2009; 119(6): 821-846.
• van Geijlswijk IM, Korzilius HP, Smits MG. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010;33(12):1605-1614.
• Kunz D, Mahlberg R. A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder. J Sleep Res. 2010; 19(4): 591-596.
• Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002; 35(3): 716-721.
• Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology. 1998; 27(2): 339-345.
• Montagnese S, Middleton B, Mani AR, Skene DJ, Morgan MY. Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome? Metab Brain Dis. 2009; 24(3): 427-439.
• Montagnese S, De Pitta C, De Rui M, Corrias M, Turco M, Merkel C i wsp. Sleep-wake abnormalities in patients with cirrhosis. Hepatology. 2014; 59(2): 705-712.
• Ardizzi A, Grugni G, Saglietti G, Morabito F. Circadian rhythm of melatonin in liver cirrhosis. Minerva Med. 1998;89(1-2):1-4.
• Velissaris D, Karamouzos V, Polychronopoulos P, Karanikolas M. Chronotypology and melatonin alterations in minimal hepatic encephalopathy. J Circadian Rhythms. 2009; 29; 7: 6.
• Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Disruption of the diurnal rhythm of plasma melatonin in cirrhosis. Ann Intern Med. 1995; 123(4): 274-277.
• Steindl PE, Finn B, Bendok B, Rothke S, Zee PC, Blei AT. Changes in the 24-hour rhythm of plasma melatonin in patients with liver cirrhosis-relation to sleep architecture]. Wien Klin Wochenschr. 1997; 109(18): 741-746.
• Coy DL, Mehta R, Zee P, Salchli F, Turek FW, Blei AT. Portal-systemic shunting and the disruption of circadian locomotor activity in the rat. Gastroenterology. 1992; 103(1): 222-228.
• Ocena jakości snu w odniesieniu do stężenia serotoniny 180 i melatoniny
• Zee PC, Mehta R, Turek FW, Blei AT. Portacaval anastomosis disrupts circadian locomotor activity and pineal melatonin rhythms in rats. Brain Res. 1991; 560(1-2): 17-22.
• Cordoba J, Steindl P, Blei AT. Melatonin arrhythmia is corrected after liver transplantation. Am J Gastroenterol. 2009; 104(7): 1862-1863.
• Chojnacki C, Romanowski M, Winczyk K, Błasiak J, Chojnacki J. Melatonin levels in serum and ascitic fluid of patients with hepatic encephalopathy. Gastroenterol Res Pract doi.10.1155/2012/510764.
• Chojnacki C, Wachowska-Kelly P, Błasiak J, Reiter RJ, Chojnacki J. Melatonin secretion and metabolism in patients with hepatic encephalopathy. J Gastroenterol Hepatol. 2013; 28(2): 342-347.
• Mostacci B, Ferlisi M, Baldi Antognini A, Sama C, Morelli C, Mondini S i wsp. Sleep disturbance and daytime sleepiness in patients with cirrhosis: a case control study. Neurol Sci. 2008; 29(4): 237-240.
• Chojnacki C, Walecka-Kapica E, Klupińska G, Wachowska-Kelly P, Żylińska K, Winczyk K i wsp. Serotonin and melatonin secretion and metabolism in patients with liver cirrhosis. Pol Arch Med Wewn. 2012; 122(9): 392-397.
• Chojnacki C, Walecka-Kapica E, Stepien A, Pawlowicz M, Wachowska-Kelly P, Chojnacki J. Serum and ascitic fluid serotonin levels and 5-hydroxyindoleacetic acid urine excretion in the liver of cirrhotic patients with encephalopathy. Adv Med Sci. 2013; 58(2): 251-256.
• Sarrias MJ, Artigas F, Martinez E, Gelpi E. Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biol Psychiatry. 1989; 26(7): 695-706.
• Shabbir F, Patel A, Mattison C, Bose S, Krishnamohan R, Sweeney E i wsp. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int. 2013; 62(3): 324-329.
• Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013; 20(1): 14-21.
• Saleem DM, Haider S, Khan MM, Shamsi T, Haleem DJ. Role of tryptophan in the pathogenesis of hepatic encephalopathy. J Pak Med Assoc. 2008; 58(2): 68-70.
• Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008; 11(3): 198-209.
• Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol. 2013; 169(6): 1211-1227.
• Dantzer R, O'Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011; 36(3): 426-436.

• Document Type: paper